On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver
Systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes parkinsonism in humans and other primates, but not in rats; mice are intermediate in their susceptibility which varies among strains. We hypothesized previously that the rat's resistance to systemic MPTP toxicity is likely due...
Saved in:
| Main Author: | Riachi, N.J. (author) |
|---|---|
| Other Authors: | Harik, S.I. (author), Kalaria, R.N. (author), Sayre, L.M. (author) |
| Format: | article |
| Published: |
1988
|
| Online Access: | http://hdl.handle.net/10725/10442 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://jpet.aspetjournals.org/content/244/2/443.short |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain
by: Riachi, N.J.
Published: (1989) -
Potent neurotoxic fluorinated 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine analogs as potential probes in models of parkinson disease
by: Riachi, Naji J.
Published: (1988) -
Strain differences in systematic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier
by: Riachi, Naji J.
Published: (1988) -
Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies
by: Riachi, N.J.
Published: (1993) -
Chemical oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its in vivo metabolism in rat brain and liver
by: Riachi, Naji J.
Published: (1988)